CES2 and metabolic dysfunction-associated steatotic liver disease: Further studies utilizing liver-specific HNF4α or CES2 knockout mice are needed to confirm the essential role of the HNF4α-CES2 pathway in the treatment of NAFLD by UC-MSCs.